A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer
Yuexian Zhou(Shanghai Jiao Tong University), Jianwei Zhu(Shanghai Jiao Tong University)
Cited by 62
Related Papers
Nectin-4-targeted immunoSPECT/CT imaging and photothermal therapy of triple-negative breast cancer
|Journal of Nanobiotechnology|2022|66
RPL21 siRNA Blocks Proliferation in Pancreatic Cancer Cells by Inhibiting DNA Replication and Inducing G1 Arrest and Apoptosis
|Frontiers in Oncology|2020|53
A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
|Acta Pharmacologica Sinica|2024|29